The Current Bulk Drug Manufacturing Scenario - Maharashtra, a Major Hub

Abstract: The bulk drug industry is highly fragmented, with a large number of small players. The global bulk drug market, worth an estimated US$77.33 billion in 2005, grew at a compounded annual growth rate (CAGR) of 9.2% in the last five years. In 2005, the Indian bulk market size was US$1.15 billion. Higher manufacturing cost in producing active pharmaceutical ingredients (API) makes the western countries look for cheaper destinations like India. To grab this opportunity, most of the companies are setting up or expanding their facilities. Since March 2006, 20 bulk drug units got a clearance from the Environmental Impact Assessment Division (IA) of the Ministry of Environment & Forest. Most of the bulk drugs and intermediate manufacturers are planning to set up new units or expanding existing operations in Gujarat, Maharashtra, Haryana, Punjab and Andhra Pradesh.

The above content is an abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate, New Delhi, India -110016
Tel.: 26855839, 20057149, Fax: 91-11-26855876
Email: info@kppub.com / fpc@vsnl.com, Website: http://www.kppub.com